ABEOW

Abeona Therapeutics (ABEOW)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABEOW
DataOraFonteTitoloSimboloCompagnia
20/06/201500:29Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:ABEOWAbeona Therapeutics Inc
20/06/201500:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABEOWAbeona Therapeutics Inc
19/06/201523:48Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ABEOWAbeona Therapeutics Inc
05/06/201512:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ABEOWAbeona Therapeutics Inc
04/06/201517:36Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ABEOWAbeona Therapeutics Inc
01/06/201523:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ABEOWAbeona Therapeutics Inc
28/05/201516:12Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ABEOWAbeona Therapeutics Inc
22/05/201522:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ABEOWAbeona Therapeutics Inc
18/05/201522:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABEOWAbeona Therapeutics Inc
15/05/201512:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ABEOWAbeona Therapeutics Inc
14/05/201522:26Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ABEOWAbeona Therapeutics Inc
11/05/201521:42Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ABEOWAbeona Therapeutics Inc
07/04/201522:38Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ABEOWAbeona Therapeutics Inc
07/04/201515:05PR Newswire (US)PlasmaTech Biopharmaceuticals Appoints Alpha-1 Expert Robert Sandhaus, MD, Ph.D. To Its Scientific Advisory BoardNASDAQ:ABEOWAbeona Therapeutics Inc
02/04/201515:05PR Newswire (US)PlasmaTech Biopharmaceuticals' Announces $5 million private placementNASDAQ:ABEOWAbeona Therapeutics Inc
01/04/201514:15PR Newswire (US)PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 AcheivementsNASDAQ:ABEOWAbeona Therapeutics Inc
31/03/201522:18Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ABEOWAbeona Therapeutics Inc
31/03/201514:45PR Newswire (US)PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In KoreaNASDAQ:ABEOWAbeona Therapeutics Inc
10/03/201514:10PR Newswire (US)PlasmaTech Biopharmaceuticals To Present at 27th Annual ROTH Capital Partners Conference - NEW TIME SLOTNASDAQ:ABEOWAbeona Therapeutics Inc
05/03/201515:10PR Newswire (US)PlasmaTech Biopharmaceuticals' Announces Initiation Of Enrollment Of MuGard® Trial For Afinitor® (Everolimus; Novartis) - R...NASDAQ:ABEOWAbeona Therapeutics Inc
03/03/201515:10PR Newswire (US)PlasmaTech Biopharmaceuticals To Present at 27th Annual ROTH Capital Partners ConferenceNASDAQ:ABEOWAbeona Therapeutics Inc
06/02/201517:13PR Newswire (US)PlasmaTech Biopharmaceuticals To Present at 17th Annual BIO CEO & Investor ConferenceNASDAQ:ABEOWAbeona Therapeutics Inc
14/01/201515:00PR Newswire (US)PlasmaTech Biopharmaceuticals to Present at Biotech Showcase 2015NASDAQ:ABEOWAbeona Therapeutics Inc
12/01/201515:15PR Newswire (US)PlasmaTech Biopharmaceuticals To Present at OneMedForum Investor Conference in San FranciscoNASDAQ:ABEOWAbeona Therapeutics Inc
05/01/201519:43Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ABEOWAbeona Therapeutics Inc
24/12/201417:59PR Newswire (US)PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public OfferingNASDAQ:ABEOWAbeona Therapeutics Inc
22/12/201423:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:ABEOWAbeona Therapeutics Inc
18/10/201018:22Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)NASDAQ:ABEOWAbeona Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABEOW
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network